https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&publication_type=transparency-data<\/a><\/p> <\/p>
<\/p>
<\/p>
Information for April \u2013 June 2014 is due to be published soon.<\/p>
<\/p>
Details of meetings with officials are not held centrally and could only be provided at disproportionate cost.<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-25T13:46:31.563Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "26"}
, "answeringDeptShortName" : {"_value" : "Business, Innovation and Skills"}
, "answeringDeptSortName" : {"_value" : "Business, Innovation and Skills"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bayer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Innovation and Skills, what meetings (a) he and (b) officials in his Department have had with Bayer plc in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3924", "label" : {"_value" : "Biography information for Yasmin Qureshi"}
}
, "tablingMemberConstituency" : {"_value" : "Bolton South East"}
, "tablingMemberPrinted" : [{"_value" : "Yasmin Qureshi"}
], "uin" : "215405"}
, {"_about" : "http://data.parliament.uk/resources/156994", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/156994/answer", "answerText" : {"_value" : "
As part of the United Kingdom\u2019s antimicrobial resistance strategy, we have been working with industry and with other national and international stakeholders on how best to stimulate the development of new antibiotics, diagnostics and potential business models as well as on research into antimicrobial resistance.<\/p>
<\/p>
<\/p>
<\/p>
We will continue to explore what can be done to support antimicrobial diagnostics and drug development pending the announcement by the independent Review on Antimicrobial Resistance of its conclusions.<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-25T13:22:48.517Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antibiotics"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, with reference to the Government's response to the House of Commons Science and Technology Committee report, Ensuring access to working antimicrobials, Cm, 8919, whether his Department is working on potential alternative pricing and reimbursement mechanisms for novel antibiotics in advance of the conclusion of the O'Neill Review; and what plans he has to explore new funding mechanisms with industry in the interim.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"}
}
, "tablingMemberConstituency" : {"_value" : "Scunthorpe"}
, "tablingMemberPrinted" : [{"_value" : "Nic Dakin"}
], "uin" : "215487"}
, {"_about" : "http://data.parliament.uk/resources/156998", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/156998/answer", "answerText" : {"_value" : "
Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed \u2018off-label\u2019 outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.<\/p>
<\/p>
<\/p>
<\/p>
My Rt. hon. Friend the Secretary of State has had no discussions with charities about the use of off-patent drugs for new indications since 2 July. Officials have had several discussions with the Breast Cancer Campaign covering their views on medicines licences, implementation of National Institute for Health and Care Excellence guidelines and planning the roundtable discussion on adoption of new evidence into clinical practice. There have also been ongoing discussions with Cancer Research UK on the use of aspirin to help prevent certain cancers.<\/p>
<\/p>
<\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T17:23:49.943Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Drugs: Licensing"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, on what dates since 2 July 2014 he has discussed with charities the use of off-patent drugs for new indications; and what the content of these discussions was.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4133", "label" : {"_value" : "Biography information for Andrew Bridgen"}
}
, "tablingMemberConstituency" : {"_value" : "North West Leicestershire"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Bridgen"}
], "uin" : "215396"}
, {"_about" : "http://data.parliament.uk/resources/156999", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/156999/answer", "answerText" : {"_value" : "
While the Department has not commissioned research, we continue to work with the Department for Business, Innovation and Skills, key partners and other stakeholders to ensure our publicly stated position is respected.<\/p>
<\/p>
<\/p>
<\/p>
We are aware of concerns about the European Union\u2013United States Transatlantic Trade and Investment Partnership (TTIP) currently being negotiated which are misplaced and inaccurate.<\/p>
<\/p>
<\/p>
<\/p>
What we can be absolutely clear on is that this Government will not allow TTIP<\/p>
<\/p>
negotiations to harm the National Health Service, and any assertion that the agreement will undermine the NHS is both irresponsible and false. Our position is supported by statements from both the European and US negotiators.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-27T17:45:56.233Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Transatlantic Trade and Investment Partnership"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what advice or research his Department has commissioned from external bodies on the potential effects on the NHS of the Transatlantic Trade and Investment Partnership.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "tablingMemberConstituency" : {"_value" : "Denton and Reddish"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"}
], "uin" : "215373"}
, {"_about" : "http://data.parliament.uk/resources/157004", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/157004/answer", "answerText" : {"_value" : "
Information on the number and net ingredient cost of prescription items for paracetamol1<\/sup> dispensed in the community in England is in the table.<\/p> <\/p>
<\/p>
<\/p>
Year<\/p><\/td> | Prescription Items<\/p> (000s)<\/p><\/td> | Net Ingredient Cost<\/p> (£000s)<\/p><\/td><\/tr> |
2012-13<\/p><\/td> | 21,963.2<\/p><\/td> | 73,793.9<\/p><\/td><\/tr> |
2013-14<\/p><\/td> | 22,616.5<\/p><\/td> | 83,146.6<\/p><\/td><\/tr><\/tbody><\/table> <\/p> 1<\/sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs<\/p> <\/p> Source:<\/em> Prescription Cost Analysis system provided by the NHS Business Services Authority<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "215407"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-25T17:07:23.74Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Paracetamol"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the cost to the public purse was of prescriptions issued for paracetamol in England in each of the last two years; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4002", "label" : {"_value" : "Biography information for Nick de Bois"}
}
, "tablingMemberConstituency" : {"_value" : "Enfield North"}
, "tablingMemberPrinted" : [{"_value" : "Nick de Bois"}
], "uin" : "215406"}
, {"_about" : "http://data.parliament.uk/resources/157005", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/157005/answer", "answerText" : {"_value" : " Information on the number and net ingredient cost of prescription items for paracetamol1<\/sup> dispensed in the community in England is in the table.<\/p> <\/p> <\/p> <\/p> Year<\/p><\/td> | Prescription Items<\/p> (000s)<\/p><\/td> | Net Ingredient Cost<\/p> (£000s)<\/p><\/td><\/tr> | 2012-13<\/p><\/td> | 21,963.2<\/p><\/td> | 73,793.9<\/p><\/td><\/tr> | 2013-14<\/p><\/td> | 22,616.5<\/p><\/td> | 83,146.6<\/p><\/td><\/tr><\/tbody><\/table> <\/p> 1<\/sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs<\/p> <\/p> Source:<\/em> Prescription Cost Analysis system provided by the NHS Business Services Authority<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-25", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "215406"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-25T17:07:23.85Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Paracetamol"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many prescriptions have been issued for paracetamol in England in each of the last two years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4002", "label" : {"_value" : "Biography information for Nick de Bois"}
}
, "tablingMemberConstituency" : {"_value" : "Enfield North"}
, "tablingMemberPrinted" : [{"_value" : "Nick de Bois"}
], "uin" : "215407"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|
|